tiprankstipranks

Amir Nashat Insider Profile

4 Followers
Amir Nashat, Director at Fate Therapeutics, holds 11.03K shares in Fate Therapeutics (Ticker: FATE), holds ― shares in aTyr Pharma (Ticker: LIFE), holds 2.27M shares in Scholar Rock Holding (Ticker: SRRK).
tipranks
Amir Nashat

Amir Nashat
Fate Therapeutics (FATE)
Director

Ranked #91,850 out of 97,825 Corporate Insiders

Profitable Transactions

31%
5 out of 16 Profitable Transactions

Average Return

-27.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$101M
64.54%
33.74%
1.65%
0.07%
0.00% Others
A breakdown of Amir Nashat's holdings

Insider Roles

Morphic Holding
(MORF)
Director
Scholar Rock Holding
(SRRK)
Director
Cartesian Therapeutics
(RNAC)
Director
Fate Therapeutics
(FATE)
Director
+2 other positions
Roles that Amir Nashat holds in companies

Most Profitable Insider Trade

Stock:
Cartesian Therapeutics
(RNAC)
Rating:Informative Buy
Date:Jan 29, 2019 - Jan 29, 2020
Return:+82.70%
The most profitable trade made by Amir Nashat

Amir Nashat's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Fate Therapeutics
Aug 02, 2019
Director
Uninformative Sell
1.40M
$75.69K
aTyr Pharma
Director
Scholar Rock Holding
Dec 29, 2023
Director
Uninformative Sell
$34.11M
Syros Pharmaceuticals
Director
Cartesian Therapeutics
Jan 29, 2019
Director
Informative Buy
1.75M
$1.67M
Morphic Holding
Jun 30, 2023
Director
Uninformative Buy
$65.26M
MTCR
Metacrine
Sep 22, 2020
Uninformative Buy
$103.97K
BINDQ
DNIB Unwind, Inc.
$0.00
RCPT
Receptos
May 29, 2014
Uninformative Buy
$887.71K
List of latest transactions for each holding click on a transaction to see Amir Nashat's performance on stock

Amir Nashat insider profile FAQ

What is the percentage of profitable transactions made by Amir Nashat?
The percentage of profitable transactions made by Amir Nashat is 31%.
    What is the average return per transaction made by Amir Nashat?
    The average return per transaction made by Amir Nashat is -27.30%.
      What stocks does Amir Nashat hold?
      Amir Nashat holds: FATE, LIFE, SRRK, SYRS, RNAC, MORF, MTCR, BINDQ, RCPT stocks.
        What was Amir Nashat’s latest transaction?
        Amir Nashat latest transaction was an Uninformative Sell of $1.40M.
          What was Amir Nashat's most profitable transaction?
          Amir Nashat’s most profitable transaction was an Informative Buy of RNAC stock on January 29, 2019. The return on the trade was 82.70%.
            What is Amir Nashat's role in Fate Therapeutics?
            Amir Nashat's role in Fate Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.